We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
129 hedge funds and large institutions have $488M invested in Amneal Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
59% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 17
56% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 32
55% more capital invested
Capital invested by funds: $314M → $488M (+$173M)
7% more funds holding
Funds holding: 121 → 129 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.07% less ownership
Funds ownership: 84.51% → 75.43% (-9.1%)
91% less call options, than puts
Call options by funds: $75K | Put options by funds: $850K
Holders
129
Holders Change
+8
Holders Change %
+6.61%
% of All Funds
2.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
50
Reduced
32
Closed
17
Calls
$75K
Puts
$850K
Net Calls
-$775K
Net Calls Change
+$124K
Top Buyers
| 1 |
BlackRock
New York
|
+$6.49M |
| 2 |
Millennium Management
New York
|
+$3.38M |
| 3 |
Bank of New York Mellon
New York
|
+$2.74M |
| 4 |
MSL
Mackay Shields LLC
New York
|
+$2.73M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.49M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$32.7M |
| 2 |
Morgan Stanley
New York
|
-$5.97M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.93M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$1.29M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.27M |
